Search Results for "Infusion Therapy Home Infusion Companies"

21:17 EST 20th November 2014 | BioPortfolio

Matching Channels

Intraosseous Infusion

CD20 Antibodies

The chimeric anti-CD20 antibody rituximab (Rituxan & MabThera) from Biogen Idec and Genentech/Roche is one of the world’s commercially most successful antibodies (2007 sales of over US$ 5 bl...

Lysosomal storage disorders (LSDs)

Lysosomal storage disorders (LSDs) represent a group of about 50 genetic disorders caused by deficiencies of lysosomal proteins. Most involve genetic mutations causing loss of function of key catabo...

Sweden

The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...

California

In addition to the Silicon Valley, California on the west coast of the USA is home to a biotechnology hub. 26% of all American biotechnology firms are located in this state, but they count for over ...

Matching News

Growing at 9.6% CAGR, Needleless Connector Is Expected to Be the Fastest Growing Segment in Global Home Infusion Therapy Market by 2020 – Persistence Market Research

Persistence Market Research is published new market report Title “Global Market Study on Home Infusion Therapy: Needleless Connectors to Witness Highest Growth by 2020”, the g...

Hillenbrand buys home infusion pump maker Block for $80mm.

Hillenbrand Industries (manufactures durable medical equipment) is entering the home health care market with its acquisition of privately-held Block Medical, a manufacturer of home infusion equipment,...

Asia-Pacific Market for Infusion Therapy Devices Led by Terumo, JMS and Nipro Medical is expected to reach over $900 million by 2020

The rise of alternate and home care clinical settings is driving the Asia-Pacific market for disposable infusion pumps, according to iData Research's 2014 Asia-Pacific infusion therapy device mark...

Global Home Infusion Therapy Market Will Reach USD 26.7 Billion in 2020: Persistence Market Research

NEW YORK, August 12, 2014 /PRNewswire/ -- Persistence Market Research released new market report on "Global Market Study on Home Infusion Therapy: Needless Connectors to Witness Highest Growth by 202...

World's First Combined Glucose Sensor and Insulin Infusion Set for Diabetics Launches

MiniMed Duo Enhances Simplicity and Comfort of Sensor Augmented Insulin Pump Therapy  Medtronic, Inc. has announced the European launch of MiniMed Duo, the world's first two-in-one breakthrough that ...

AxelaCare Health Solutions Acquires Advanced Care of New York

LENEXA, Kan., Oct. 2, 2014 /PRNewswire/ -- AxelaCare Health Solutions, www.axelacare.com, a leading provider of specialty home infusion services, announced today that it has acquired Advanced Car...

Syringe Pump

Supporting a broad range of micro and macro fluidic applications, the Pump 11 Elite enables infusion operations at user-defined flow rates with selectable target volume or time values to control the t...

BioScrip To Present At Jefferies 2014 Global Healthcare Conference

ELMSFORD, N.Y., May 27, 2014 /PRNewswire/ -- BioScrip®, Inc. (NASDAQ: BIOS) today announced that the Company will present at the Jefferies 2014 Global Healthcare Conference on June 2-5, 2014...

Matching PubMed Articles

Long-Term Home Parenteral Nutrition: It Takes an Interdisciplinary Approach.

Home parenteral nutrition (HPN) is indicated for adults and children who cannot digest and absorb food and who are able to receive therapy safely outside of a hospital. How successful this therapy is ...

Making the Business Case for Infusion Teams: The Purpose, People, and Process.

A randomized controlled comparison of flushing protocols in home care patients with peripherally inserted central catheters.

Research has failed to demonstrate an optimal flushing solution or frequency for central catheters. In a 2002 study of 50 000 home care patients, catheter dysfunction with loss of patency was the most...

Successful rechallenge of cetuximab following severe infusion-related reactions: a case report.

Cetuximab, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody, is associated with a risk of infusion reactions, similar to other infusional agents. Although avoiding a rechallenge wit...

Extended-Infusion versus Standard-Infusion Piperacillin-Tazobactam for Sepsis Syndromes at a Tertiary Medical Center.

Piperacillin-tazobactam (PTZ) is frequently used as both empiric and targeted therapy for Gram-negative sepsis. Time-dependent killing properties of PTZ support the use of extended-infusion (EI) dosin...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement